Menu Search
Investment Trusts

Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

Actions
  • Price (GBX)362.86
  • Today's Change-0.14 / -0.04%
  • Shares traded121.56k
  • 1 Year change+18.97%
  • Beta0.5963
Data delayed at least 20 minutes, as of Nov 22 2024 12:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PricePolar Capital Global Healthcare Trust (Ordinary Share)+19.95%
NAVPolar Capital Global Healthcare Trust (Ordinary Share)+14.36%
Morningstar's BenchmarkMSCI ACWI/Health Care NR GBP enhanced--
--
More ▼

Key statistics

As of last trade Polar Capital Global Healthcare Trust (PCGH:LSE) traded at 362.86, -9.74% below its 52-week high of 402.00, set on Aug 30, 2024.
52-week range
Today
302.56Nov 22 2023402.00Aug 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding121.27m
Market cap440.21m GBP
Total assets463.64m GBP
Total expense ratio0.94%
High369.00
Low361.00
Previous close363.00
Average volume357.94k
YTD Change+9.96%
Beta0.5963
Diluted NAV (est)385.79
Diluted NAV (last pub)378.25
Premium/Discount-5.91%
Net Gearing0.00%
Annual div (ADY)2.40
GBX
Annual div yield (ADY)0.66%
Div ex-dateAug 01 2024
Div pay-dateAug 30 2024
Data delayed at least 20 minutes, as of Nov 22 2024 12:45 GMT.
More ▼

Annual Reports

Board of Directors

1/3

Lisa Arnold, Chairman

2/3

Neal Ransome, Director

3/3

Jeremy Whitley, Director

Further Information

Contact

The Company Secretary can be contacted at the Registered Office.

Registered Office:
16 Palace Street
London
SW1E 5JD

T: +44 (0) 20 7227 2700
F: +44 (0) 20 7227 2799
E: investor-relations@polarcapital.co.uk
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.